FDA Approved: DULOXETINE HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approves a supplemental application for duloxetine hydrochloride as a generic product from Alembic Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathic Pain
• Fibromyalgia
• Generalized Anxiety Disorder
• Major Depressive Disorder
• Musculoskeletal Pain

Drugs mentioned

• Duloxetine hydrochloride (duloxetine)

Snippet

SUPPL AP for DULOXETINE HYDROCHLORIDE (DULOXETINE)